Anxiety disorders, such as post-traumatic stress disorder (PTSD), are the most commonly occurring disorders of the psychiatric illnesses and constitute an immense economic burden. The present invention relates the use of an isolated Mycobacterium vaccae in the manufacture of a medicament for treating or preventing post-traumatic stress disorder (PTSD) and the symptoms associated with such a disorder.